 MELBOURNE, Australia, Feb. 10, 2022 GLOBE NEWSWIRE -- Opthea Limited ASX:OPT; Nasdaq:OPT, a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, announced today that Dr Megan Baldwin, the Companys Chief Executive Officer, will participate in a fireside chat at the SVB Leerink Global Healthcare Conference, being held virtually from February 14-18, 2022. 